Sitafloxacin

Sitafloxacin (also called DU-6859a) is a fluoroquinolone antibiotic that shows promise in the treatment of Buruli ulcer. The molecule was identified by Daiichi Pharmaceutical Co. Ltd, who have also brought ofloxacin and levofloxacin to the market. Sitafloxacin is currently under development in Japan.